Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-12-21 08:48:24
Reporting Period:
Filing Date:
Accepted Time:
2015-12-21 08:48:24
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1135906 Epirus Biopharmaceuticals Inc. EPRS Pharmaceutical Preparations (2834) 043514457
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657494 Aurentz Vincent C/o Epirus Biopharmaceuticals, Inc.
699 Boylston Street, 8Th Floor
Boston MA 02116
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-17 2,200 $3.43 2,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,800 Indirect Purchased by Spouse
  1. All shares were purchased by the Reporting Person's spouse for child's custodial account, for which such spouse serves as custodian.